(RTTNews) - Drug makers Exelixis, Inc. (EXEL) and Merck & Co Inc.(MRK) announced Monday that they have entered into a clinical development collaboration to evaluate the combination of Exelixis ...
German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...
Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...
The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously ...
Merck & Co., Inc. es una compañía global de cuidado de la salud. La compañía ofrece soluciones de salud a través de sus medicamentos recetados, vacunas, terapias biológicas y productos de ...
Merck KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent ...
British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of ...
German science and technology company Merck lowered mid-term targets for its Life Sciences and Healthcare businesses, ...
DPA International on MSN1d
German science and tech giant Merck confirms full-year guidanceGerman science and technology giant Merck on Thursday said it is confident of returning to medium-term growth after a ...
The global Cattle & Porcine/Swine Reproductive Diseases market is expected to grow to USD 975.8 Million by 2029, up from USD ...
Aquí tienes una recopilación con todos los logos de coches, un artículo en el que encontrarás los emblemas de las marcas de automóviles más destacadas de cuantas operan en el mercado ...
EXEL is set to evaluate investigational zanzalintinib in combination with Merck;s Keytruda (pembrolizumab) and Welireg in head and neck cancer and renal cell carcinoma, respectively. ALAMEDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback